Page 189 - Read Online
P. 189

Page 16 of 17                                         Chen et al. Mini-invasive Surg 2018;2:42  I  http://dx.doi.org/10.20517/2574-1225.2018.59


                   assessment with the EORTC QLQ-C30 and SF-36 questionnaires. Tumori 2002;88:110-6.
               10.  Gujral S, Conroy T, Fleissner C, Sezer O, King PM, et al. Assessing quality of life in patients with colorectal cancer: an update of the
                   EORTC quality of life questionnaire. Eur J Cancer 2007;43:1564-73.
               11.  Uwer L, Rotonda C, Guillemin F, Miny J, Kaminsky MC, et al. Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality
                   of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes 2011;9:70.
               12.  Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life
                   questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur
                   J Cancer 1999;35:238-47.
               13.  Batista-Miranda JE, Regalado Pareja R, Huguet Pérez J, Montlleo Sánchez M, Araño Bertran P. The use of the IPSS questionnaire in
                   surgical patients. International Prostatic Symptom Score. Actas Urol Esp 1995;19:227-33. (in Spanish)
               14.  Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, et al. The international index of erectile function (IIEF): a multidimensional
                   scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
               15.  de Silva G, Furukan R, Goonewardene M. Validation of the Sinhala translation of the international consultation on incontinence modular
                   questionnaire for female lower urinary tract symptoms among women in Sri Lanka. Int Urogynecol J 2017;28:1895-9.
               16.  Pourmomeny AA, Ghanei B, Alizadeh F. Alizadeh. Reliability and validity of the persian language version of the international
                   consultation on incontinence questionnaire - male lower urinary tract symptoms (ICIQ-MLUTS). Low Urin Tract Symptoms
                   2018;10:190-2.
               17.  Vroege JA. The sexual health inventory for men (IIEF-5). Int J Impot Res 1999;11:177.
               18.  Rosen R, Brown C, Heiman J, Leiblum S, Meston C, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report
                   instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
               19.  Moghadamyeghaneh Z, Carmichael JC, Mills S, Pigazzi A, Nguyen NT, et al. Variations in laparoscopic colectomy utilization in the
                   United States. Dis Colon Rectum 2015;58:950-6.
               20.  Breukink SO, van der Zaag-Loonen HJ, Bouma EM, Pierie JP, Hoff C, et al. Prospective evaluation of quality of life and sexual
                   functioning after laparoscopic total mesorectal excision. Dis Colon Rectum 2007;50:147-55.
               21.  Braga M, Frasson M, Vignali A, Zuliani W, Capretti G, et al. Laparoscopic resection in rectal cancer patients: outcome and cost-benefit
                   analysis. Dis Colon Rectum 2007;50:464-71.
               22.  George D, Pramil K, Kamalesh NP, Ponnambatheyil S, Kurumboor P. Sexual and urinary dysfunction following laparoscopic total
                   mesorectal excision in male patients: a prospective study. J Minim Access Surg 2018;14:111-7.
               23.  Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in
                   patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365:1718-26.
               24.  Jeong SY, Park JW, Nam BH, Kim S, Kang SB, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after
                   neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial.
                   Lancet Oncol 2014;15:767-74.
               25.  Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, et al. A randomized trial of laparoscopic versus open surgery for rectal
                   cancer. N Engl J Med 2015;372:1324-32.
               26.  Andersson J, Abis G, Gellerstedt M, Angenete E, Angerås U, et al. Patient-reported genitourinary dysfunction after laparoscopic and
                   open rectal cancer surgery in a randomized trial (COLOR II). Br J Surg 2014;101:1272-9.
               27.  Fleshman J, Branda M, Sargent DJ, Boller AM, George V, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or
                   III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314:1346-55.
               28.  Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, et al. Effect of laparoscopic-assisted resection vs open resection on
                   pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015; 314:1356-63.
               29.   D'Annibale A, Pernazza G, Monsellato I, Pende V, Lucandri G, et al. Total mesorectal excision: a comparison of oncological and
                   functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc 2013;27:1887-95.
               30.   Kim JY, Kim NK, Lee KY, Hur H, Min BS, et al. A comparative study of voiding and sexual function after total mesorectal excision
                   with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol 2012;19:2485-93.
               31.   Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP. Short-term clinical outcome of robot-assisted intersphincteric resection for low rectal
                   cancer: a retrospective comparison with conventional laparoscopy. Surg Endosc 2013;27:48-55.
               32.  Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP, et al. Urinary and erectile function in men after total mesorectal excision by laparoscopic
                   or robot-assisted methods for the treatment of rectal cancer: a case-matched comparison. World J Surg 2014;38:1834-42.
               33.  Broholm M, Pommergaard HC, Gögenür I. Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual
                   dysfunction: a systematic review and meta-analysis. Colorectal Dis 2015;17:375-81.
               34.  Kamali D, Omar K, Imam SZ, Jha A, Reddy A, et al. Patient quality of life and short-term surgical outcomes between robotic and
                   laparoscopic anterior resection for adenocarcinoma of the rectum. Tech Coloproctol 2017;21:355-61.
               35.  Kim HJ, Choi GS, Park JS, Park SY, Yang CS, et al. The impact of robotic surgery on quality of life, urinary and sexual function
                   following total mesorectal excision for rectal cancer: a propensity score-matched analysis with laparoscopic surgery. Colorectal Dis
                   2018;20:O103-13.
               36.  Kim JC, Lim SB, Yoon YS, Park IJ, Kim CW, et al. Completely abdominal intersphincteric resection for lower rectal cancer: feasibility
                   and comparison of robot-assisted and open surgery. Surg Endosc 2014;28:2734-44.
               37.  Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of
                   conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA
                   2017;318:1569-80.
               38.  Clancy C, Burke JP, Albert MR, O'Connell PR, Winter DC. Transanal endoscopic microsurgery versus standard transanal excision for
                   the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum 2015;58:254-61.
   184   185   186   187   188   189   190   191   192   193   194